STAT+: Lilly’s breast cancer combo wins approval
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi! Today we have some consolidation in radiopharma, an early ADHD signal for orexin agonists, and a call from Reed Jobs to…
ImpactMinor 11/100
Why it mattersRule-based estimate: event keywords (+4), soft/evergreen signals; trust 8/10.
RegionsGlobal
Published5 h ago (Mon, 21 Sep 2026 15:08:38 GMT)
RetrievedMon, 21 Sep 2026 17:00:53 GMT via rss
ClassifiedMon, 21 Sep 2026 18:01:24 GMT by heuristic
AuthorSTAT Staff